Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
No Data
Neurotech Director Options Expire Without Exercise
Maybank Securities Exits Substantial Holder Position in Neurotech International
Neurotech Showcases Paediatric Neurology Drug NTI164 at Hong Kong Investment Summit
Neurotech Director Mark Davies Increases Indirect Shareholding
Neurotech Clears Secondary Trading for New Share Issue
Neurotech International Seeks ASX Quotation for 21.4 Million New Shares